Cochrane · systematic review · CD015255

Topical and oral steroids for otitis media with effusion (OME) in children

Mulvaney, CA, Galbraith, K, Webster, KE, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library

ENTAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
16
current version
GRADE rated
12
No studies
4
Included studies
NR
No studies 4 · 25%Ungraded 0 · 0%Very low 6 · 37.5%Low 4 · 25%Moderate 2 · 12.5%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Oral steroids compared to placebo for otitis media with effusion (OME) in children

Population: children aged 6 months to 12 years with otitis media with effusion (OME)
4 questions
OutcomeEffectEvidenceStatus / GRADE
Hearing ‐ return to normal hearing
Oral steroids vs placebo
RR 1.14 [0.97, 1.33]NRModerate
Downgraded: imprecision
Disease‐specific quality of life (total OM8‐30, lower score is more favourable)
Oral steroids vs placebo
no estimate extractedNRModerate
Downgraded: risk of bias, imprecision
Presence/persistence of OME
Oral steroids vs placebo
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Adverse event: systemic corticosteroid side effects
Oral steroids vs placebo
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision

Oral steroids compared to no treatment for otitis media with effusion (OME) in children

Population: children aged 6 months to 12 years with otitis media with effusion (OME)
4 questions
OutcomeEffectEvidenceStatus / GRADE
Hearing
Oral steroids vs no treatment
no estimate extractedNRNo studies
Disease‐specific quality of life
Oral steroids vs no treatment
no estimate extractedNRNo studies
Presence/persistence of OME (3 to 9 months ‐ medium‐term) № of participants: 258 (2 RCTs)
Oral steroids vs no treatment
RR 1.02 [0.89, 1.17]NRLow
Downgraded: risk of bias
Adverse event: systemic corticosteroid side effects
Oral steroids vs no treatment
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision

Topical (intranasal) steroids compared to placebo for otitis media with effusion (OME) in children

Population: children aged 6 months to 12 years with otitis media with effusion (OME)
4 questions
OutcomeEffectEvidenceStatus / GRADE
Hearing ‐ hearing threshold; assumed ICC = 0.5
Topical (intranasal) steroids vs placebo
no estimate extractedNRVery low
Downgraded: risk of bias
Disease‐specific quality of life (total OM8‐30 score, lower score is more favourable)
Topical (intranasal) steroids vs placebo
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Presence/persistence of OME
Topical (intranasal) steroids vs placebo
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision
Adverse event: systemic corticosteroid side effects
Topical (intranasal) steroids vs placebo
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision

Topical (intranasal) steroids compared to no treatment for otitis media with effusion (OME) in children

Population: children aged 6 months to 12 years with otitis media with effusion (OME)
4 questions
OutcomeEffectEvidenceStatus / GRADE
Hearing ‐ hearing threshold (air‐bone gap, very short‐term); assumed ICC = 0.5
Topical (intranasal) steroids vs no treatment
no estimate extractedNRLow
Downgraded: risk of bias
Disease‐specific quality of life
Topical (intranasal) steroids vs no treatment
no estimate extractedNRNo studies
Presence/persistence of OME (short‐term); assumed ICC = 0.5
Topical (intranasal) steroids vs no treatment
RR 0.72 [0.57, 0.91]NRVery low
Downgraded: risk of bias, imprecision
Adverse event: systemic corticosteroid side effects
Topical (intranasal) steroids vs no treatment
no estimate extractedNRNo studies